Skip to main content

Table 1 Preoperative baseline characteristics of patients undergoing solitary SAVR with CE-Perimount bioprosthesis

From: Long-term survival after Carpentier-Edwards Perimount aortic valve replacement in Western Denmark: a multi-centre observational study

Patients, n 1604
Male, n (%) 984 (61.3%)
Age
 Median (IQR) 73 (69–78)
 Mean, years (Range) 72.7 (20–91)
Etiology, n (%)
 Aortic Stenosis 1204 (75.1%)
 Aortic Insufficience 248 (15.5%)
 Stenosis and Insufficience 7 (0.4%)
 Endocarditis 30 (1.9%)
 Others incl. Missing 115 (7.2%)
Valve size, n = 1601 (%)
 19 mm 103 (6.4%)
 21 mm 346 (21.6%)
 23 mm 564 (35.2%)
 25 mm 412 (25.7%)
 27 mm 156 (9.7%)
 29 mm 20 (1.3%)
EOAI ≥0,85 (%), n = 1483 1295 (87.3%)
Ejection Fraction, n = 1469
 Mean % (95% CI) 53 (52.55–53.89)
 Range 0–92
Smoking, n = 1473
 Active smoker 237 (14.8%)
 Non-smoker 524 (32.8%)
 Previous smoker 712 (44.6%)
EuroSCORE II, n = 1604
 Mean ± SD (95% CI) 1.45 ± 2.08 (1.35–1.55)
 Range, score 0.5–39.62
Diabetes mellitus, n = 1561 (%) 204 (13.1%)
Previous AMI, n = 1557 (%) 119 (7.6%)
Previous PCI, n = 1555 (%) 110 (7.1%)
Lipid-lowering treatment, n = 1538 (%) 707 (46%)
Hypertension treatment, n = 1528 (%) 873 (57.1%)
Previous Operations, n = 1602 (%)
 0 1476 (92.1%)
 Previois aortic valve operation 11 (0.7%)
 Other heart surgery 39 (2.4%)
BSA, n = 1486
 Mean ± SD, m2 (95% CI) 1.89 ± 0.2 (1.88–1.90)
 Range, m2 1.34–2.67
  1. BSA Body surface area, EOAI effective orifice area index, IQR Interquartile range;